GST-HG131 tablets

GST-HG131 · Fujian Akeylink Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GST-HG131 tablets, covering 2025-03-05 to 2025-03-05. Get the full timeline:

Most recent: Clinical Trial Update: A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of GST-HG131 Tablets in Patients With Chronic Hepatitis B [Phase 2]

See pricing